Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Stateside's Canadian Microcap Board -- Ignore unavailable to you. Want to Upgrade?

To: ayeyou who wrote (1691)	9/26/2016 6:53:22 AM
From: Dave@SI	Read Replies (1) \| Respond to of 1728

BCT - mention of SH on what BioNap's renumeration is, I hadn't noticed: - BriaCell Therapeutics (BCT.V) at a rate of $2,000 per month to BioNap and has granted Jason Napodano, founder and chief officer of BioNap, 500,000 stock options exercisable at $0.255 per share for the provision of research reports and investor relations services. so I guess when he says he is "long" I guess he means the options? But odd this was not mentioned in May.